MedTrace Logo

Protective Effect of N-acetylcysteine on Early Outcomes of Deceased Renal Transplant

NCT00994305 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2009-10-14

No results posted yet for this study

Summary

Investigate the therapeutic effects of the antioxidant N-acetylcysteine on early outcomes of deceased renal transplant patients.

Conditions

  • Renal Transplantation

Interventions

DRUG

N-acetylcysteine

600 mg bid po 0-7 PO

DRUG

control

No treatment: standard care provided. No N-acetylcysteine administration.

Sponsors & Collaborators

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

    collaborator OTHER_GOV

  • University of Sao Paulo General Hospital

    lead OTHER

Principal Investigators

  • Alexandre Danilovic, MD · University of Sao Paulo General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2008-06-30
Completion
2009-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00994305 on ClinicalTrials.gov